Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
555.95B | 540.15B | 456.48B | 389.90B | 374.21B | 404.43B | Gross Profit |
262.70B | 254.89B | 204.46B | 172.81B | 164.17B | 176.51B | EBIT |
78.83B | 78.80B | 44.41B | 30.68B | 31.60B | 35.59B | EBITDA |
97.11B | 111.51B | 64.08B | 48.73B | 49.16B | 54.38B | Net Income Common Stockholders |
48.27B | 61.69B | 38.92B | 21.27B | 19.22B | 14.69B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
173.54B | 139.88B | 121.44B | 117.69B | 102.92B | 101.52B | Total Assets |
708.73B | 672.87B | 618.64B | 555.82B | 519.08B | 489.68B | Total Debt |
24.13B | 32.88B | 57.07B | 54.05B | 54.65B | 59.44B | Net Debt |
-149.41B | -101.55B | -64.36B | -63.64B | -48.27B | -42.08B | Total Liabilities |
229.08B | 228.10B | 231.81B | 215.47B | 204.31B | 198.21B | Stockholders Equity |
468.89B | 436.64B | 379.63B | 333.59B | 308.32B | 285.90B |
Cash Flow | Free Cash Flow | ||||
0.00 | 39.70B | 19.58B | 33.52B | 16.33B | 14.12B | Operating Cash Flow |
0.00 | 63.83B | 40.42B | 51.64B | 32.84B | 31.13B | Investing Cash Flow |
0.00 | 2.65B | -32.94B | -28.33B | -18.62B | -18.18B | Financing Cash Flow |
0.00 | -57.50B | -10.93B | -16.16B | -17.11B | 4.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥674.55B | 16.22 | 1.90% | 3.24% | 36.34% | ||
78 Outperform | $1.43T | 18.92 | 19.46% | 2.43% | ― | ― | |
77 Outperform | ¥946.54B | 17.69 | 11.39% | 1.56% | 4.12% | -14.50% | |
76 Outperform | ¥1.03T | 14.21 | 16.07% | 2.31% | 15.14% | 8.30% | |
68 Neutral | ¥279.84B | 26.04 | 4.03% | 3.28% | 2.87% | 2.48% | |
66 Neutral | $1.80T | 20.41 | 12.94% | 1.33% | 15.14% | 246.85% | |
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% |